Macrobid is absolutely contraindicated in patients with a history of Stevens-Johnson syndrome
Nitrofurantoin (Macrobid) should never be administered to a patient with a prior history of Stevens-Johnson syndrome (SJS). The FDA drug label explicitly states that Macrobid is contraindicated in patients with known hypersensitivity to nitrofurantoin 1, and the adverse effects section specifically lists "exfoliative dermatitis and erythema multiforme (including Stevens-Johnson syndrome)" as documented rare but serious dermatologic reactions to this medication 1.
Why This Is an Absolute Contraindication
Re-exposure to a drug that previously caused SJS carries an extremely high risk of recurrence, often with greater severity. The fundamental principle in SJS/TEN management is immediate and permanent discontinuation of the culprit drug 2, 3. Once a patient has experienced SJS from any medication, that drug becomes permanently contraindicated for life.
The mechanism involves:
- Type IV delayed hypersensitivity reaction with T-cell mediated cytotoxicity
- Immunologic memory that persists indefinitely
- Re-challenge can trigger faster onset and more severe reactions
- Risk of progression to toxic epidermal necrolysis (TEN) with mortality rates of 25-35%
Clinical Evidence
Nitrofurantoin is a documented cause of SJS, as evidenced by:
- Published case reports of nitrofurantoin-induced SJS requiring burn unit care 4
- Recognition in the literature of nitrofurantoin causing DRESS syndrome and Stevens-Johnson syndrome 5
- FDA labeling that explicitly warns of this severe cutaneous adverse reaction 1
Critical Management Points
If this patient requires treatment for a urinary tract infection:
- Choose an alternative antibiotic class entirely (never use nitrofurantoin or any related compounds)
- Document the nitrofurantoin allergy prominently in the medical record as "Stevens-Johnson syndrome"
- Consider alternatives such as trimethoprim-sulfamethoxazole (if no sulfa allergy history), fosfomycin, or fluoroquinolones depending on local resistance patterns and patient factors
- Ensure allergy documentation includes the specific reaction type (SJS) to prevent future inadvertent exposure
Common pitfall to avoid: Do not assume that because the patient tolerated nitrofurantoin previously without issue that it is now safe. SJS can occur after multiple uneventful exposures to a medication, but once it has occurred, re-exposure is absolutely contraindicated.
The UK guidelines emphasize that determining drug causality and ensuring permanent avoidance of the culprit medication is a cornerstone of SJS/TEN management 2, 3. All suspected medications must be documented and avoided for life, with consideration for referral to drug allergy specialists in complex cases 3.